Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


National Biosecurity Panel Lays Groundwork For Identifying Dual-Use Research

This article was originally published in The Pink Sheet Daily

Executive Summary

National Science Advisory Board for Biosecurity agree any criteria will need to be periodically reassessed and possibly modified to ensure relevance and applicability.

You may also be interested in...

“Pharmaco-Metabonomics” Holds Promise for Personalized Drug Therapies, Researchers Say

The method uses a combination of advanced chemical analysis and mathematical modeling to predict drug response.

NCI-Funded Researchers Are Patenting At Surprisingly High Rate, Report Says

More than one in four National Cancer Institute-funded scientists start their own healthcare companies based on their own discoveries.

U.S. Overtakes Europe In New Drug Introductions, Study Finds

U.S. overtakes Europe in innovation between 1993 and 2003, introducing the most first-in-class, biotech and orphan products in the global market, according to a study authored by a Duke University economics professor





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts